Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG in Transplant Donors to Reduce Infections
NCT05799716Phase 4Unknown
- Sponsor
- Shanghai Changzheng Hospital
- Start
- Apr 2023
- Primary completion
- Apr 2024
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 4 trial of immune globulin in Bacteremia, Viremia, kidney transplant rejection, sponsored by Shanghai Changzheng Hospital. Status: unknown.
02
Drugs
immune globulin
03
Conditions
BacteremiaViremiakidney transplant rejection
Beyond the preview
Go deeper on NCT05799716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05799716.